Laser Assisted Drug Delivery in the Treatment of Superficial Non Melanoma Skin Cancer: a Randomized Controlled Trial
Conditions: Bowen's Disease; Superficial Basal Cell Carcinoma Interventions: Device: full ablative CO2 laser; Device: fractional ablative CO2 laser; Drug: MAL; Device: LED lamp; Drug: lidocaine hydrochloride 2% with epinephrine Sponsor: University Hospital, Ghent Recruiting - verified January 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cancer | Cancer & Oncology | Carcinoma | Hospitals | Melanoma | Nonmelanoma Skin Cancer | Skin | Skin Cancer